First Tracks Biotherapeutics, Inc.
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 25 | Q1 26 | Q2 26 |
|---|---|---|---|
| – | – | -37.0% | |
| – | – | -38.6% | |
| – | -35.5% | -32.4% | |
| – | -25.7% | -41.3% | |
| – | – | -56.7% | |
| – | – | -62.4% | |
| – | – | – | |
| – | – | -65.9% | |
| – | -34.3% | -34.4% | |
| – | – | – | |
| – | +0.0% | +1.8% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.